| Primary |
| Pulmonary Arterial Hypertension |
53.7% |
| Pulmonary Hypertension |
25.6% |
| Cor Pulmonale Chronic |
13.7% |
| Product Used For Unknown Indication |
2.5% |
| Primary Pulmonary Hypertension |
1.3% |
| Portopulmonary Hypertension |
0.4% |
| Systemic Lupus Erythematosus |
0.4% |
| Hypertension |
0.3% |
| Pulmonary Hypertension Secondary |
0.3% |
| Systemic Sclerosis |
0.3% |
| Chronic Pulmonary Heart Disease |
0.2% |
| Cor Pulmonale |
0.2% |
| Pain |
0.2% |
| Prophylaxis |
0.1% |
| Pulmonary Artery Wall Hypertrophy |
0.1% |
| Pulmonary Fibrosis |
0.1% |
| Scleroderma |
0.1% |
| Atrial Septal Defect |
0.1% |
| Budd-chiari Syndrome |
0.1% |
| Cardiac Failure Congestive |
0.1% |
|
| Death |
79.3% |
| Device Related Infection |
3.3% |
| Vomiting |
2.2% |
| Infusion Site Infection |
1.7% |
| Sepsis |
1.6% |
| Pneumonia |
1.5% |
| Pulmonary Hypertension |
1.3% |
| Right Ventricular Failure |
1.2% |
| Dyspnoea |
1.1% |
| Pulmonary Arterial Hypertension |
0.9% |
| Injection Site Infection |
0.8% |
| Syncope |
0.7% |
| Diarrhoea |
0.7% |
| Hypotension |
0.6% |
| Fluid Retention |
0.6% |
| Hospitalisation |
0.6% |
| Renal Failure |
0.6% |
| Haemoptysis |
0.5% |
| Pain In Extremity |
0.5% |
| Nausea |
0.5% |
|
| Secondary |
| Pulmonary Arterial Hypertension |
52.6% |
| Pulmonary Hypertension |
17.2% |
| Product Used For Unknown Indication |
14.7% |
| Cor Pulmonale Chronic |
7.2% |
| Systemic Sclerosis |
1.0% |
| Connective Tissue Disorder |
0.7% |
| Portopulmonary Hypertension |
0.7% |
| Unevaluable Event |
0.7% |
| Crest Syndrome |
0.5% |
| Drug Abuse |
0.5% |
| Drug Therapy |
0.5% |
| Heart Disease Congenital |
0.5% |
| Hypertension |
0.5% |
| Pruritus |
0.5% |
| Scleroderma |
0.5% |
| Thyroid Cancer |
0.5% |
| Arthritis |
0.2% |
| Atrial Septal Defect |
0.2% |
| Cardiac Septal Defect |
0.2% |
| Essential Hypertension |
0.2% |
|
| Pulmonary Arterial Hypertension |
11.6% |
| Device Related Infection |
9.8% |
| Pyrexia |
7.1% |
| Syncope |
7.1% |
| Pain In Extremity |
6.3% |
| Vomiting |
6.3% |
| Dyspnoea |
5.4% |
| Death |
4.5% |
| Right Ventricular Failure |
4.5% |
| Tachycardia |
4.5% |
| Diarrhoea |
3.6% |
| Infection |
3.6% |
| Infusion Site Pain |
3.6% |
| Malaise |
3.6% |
| Pain |
3.6% |
| Pulmonary Oedema |
3.6% |
| Sepsis |
3.6% |
| Chest Pain |
2.7% |
| Hypotension |
2.7% |
| Pneumonia |
2.7% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
46.9% |
| Product Used For Unknown Indication |
20.7% |
| Pulmonary Hypertension |
18.5% |
| Cor Pulmonale Chronic |
2.4% |
| Scleroderma |
1.6% |
| Drug Use For Unknown Indication |
1.0% |
| Connective Tissue Disorder |
0.8% |
| Portopulmonary Hypertension |
0.8% |
| Cardiac Failure Congestive |
0.8% |
| Hypertension |
0.8% |
| Heart Disease Congenital |
0.7% |
| Depression |
0.7% |
| Hypothyroidism |
0.7% |
| Systemic Lupus Erythematosus |
0.6% |
| Asthma |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Anaemia |
0.5% |
| Anticoagulant Therapy |
0.5% |
| Anxiety |
0.5% |
| Hiv Infection |
0.5% |
|
| Death |
16.3% |
| Pneumonia |
8.6% |
| Dyspnoea |
7.3% |
| Pulmonary Arterial Hypertension |
6.6% |
| Device Related Infection |
6.1% |
| Right Ventricular Failure |
6.1% |
| Syncope |
5.6% |
| Pulmonary Hypertension |
5.4% |
| Unevaluable Event |
5.0% |
| Vomiting |
4.3% |
| Pyrexia |
4.0% |
| Sepsis |
4.0% |
| Oedema Peripheral |
3.1% |
| Fluid Retention |
3.0% |
| Oedema |
3.0% |
| Infection |
2.8% |
| Nausea |
2.3% |
| Renal Failure |
2.3% |
| Hypotension |
2.1% |
| Respiratory Failure |
2.1% |
|
| Interacting |
| Pulmonary Hypertension |
100.0% |
|
|
